Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
GC Biopharma Corp (006280 KS)
Watchlist
101
Analysis
Health Care
•
South Korea
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. It manufactures household medical drugs. The Company's product includes medicines for cold and fever, nutrition, antiseptic drug, and a lip balm.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Kakao Games
•
18 Jun 2021 03:18
KRX BBIG Index Rebalance Preview: Worth a Look
There are lots of changes expected to the KRX BBIG indices at the September review. With a large amount of assets tracking the indices, some of the...
Brian Freitas
Follow
609 Views
Share
bullish
•
LG Corp
•
27 Apr 2021 13:56
Closing the Gap: Korean Holdcos Vs. Opcos
In this insight, we highlight the closing of the pricing gaps between the major Korean holdcos and opcos, especially with the upcoming end of the...
Douglas Kim
Follow
485 Views
Share
bullish
•
SK Bioscience
•
24 Feb 2021 23:47
SK Bioscience IPO - Valuation Analysis
We believe that SK Bioscience's market cap value could be about 11.5 trillion won or 149,000 won per share which would represent 129% higher than...
Douglas Kim
Follow
385 Views
Share
bearish
•
Pearl Abyss
•
21 Feb 2021 08:19
KRX BBIG K-NewDeal Index Rebalance: First Set of Changes Announced
The KRX has announced changes to the KRX New Deal indices that will be effective after the close of trading on 25 February. Pearl Abyss is...
Brian Freitas
Follow
577 Views
Share
bullish
•
SK Bioscience
•
06 Feb 2021 18:23
SK Bioscience IPO Preview - Biggest IPO in Korea in 1Q 2021
SK Bioscience is getting ready to complete its IPO in Korea in March. SK Bioscience will be the biggest IPO in Korea so far this year in 2021. The...
Douglas Kim
Follow
549 Views
Share
First
Previous
5
6
7
8
9
10
11
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x